HomeSUVENPHAR • NSE
add
Suven Pharmaceuticals Ltd
Previous close
₹1,199.85
Day range
₹1,140.10 - ₹1,203.00
Year range
₹541.00 - ₹1,287.90
Market cap
295.30B INR
Avg Volume
436.57K
P/E ratio
122.67
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 2.31B | -33.62% |
Operating expense | 734.80M | 23.33% |
Net income | 607.70M | -49.61% |
Net profit margin | 26.34 | -24.09% |
Earnings per share | — | — |
EBITDA | 794.81M | -52.13% |
Effective tax rate | 26.86% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.21B | 68.63% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 20.51B | — |
Shares outstanding | 254.27M | — |
Price to book | 14.89 | — |
Return on assets | — | — |
Return on capital | 7.86% | — |
Cash Flow
Net change in cash
(INR) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 607.70M | -49.61% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
1,052